115 related articles for article (PubMed ID: 38847230)
1. Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP9.
Thi TN; Thanh HD; Nguyen VT; Kwon SY; Moon C; Hwang EC; Jung C
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38847230
[TBL] [Abstract][Full Text] [Related]
2. IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9.
Huang Q; Lan F; Wang X; Yu Y; Ouyang X; Zheng F; Han J; Lin Y; Xie Y; Xie F; Liu W; Yang X; Wang H; Dong L; Wang L; Tan J
Mol Cancer; 2014 Jan; 13():18. PubMed ID: 24479681
[TBL] [Abstract][Full Text] [Related]
3. CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
Gao Y; Guan Z; Chen J; Xie H; Yang Z; Fan J; Wang X; Li L
Int J Oncol; 2015 Aug; 47(2):690-700. PubMed ID: 26058729
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9.
Zhang BG; Du T; Zang MD; Chang Q; Fan ZY; Li JF; Yu BQ; Su LP; Li C; Yan C; Gu QL; Zhu ZG; Yan M; Liu B
Oncotarget; 2014 Nov; 5(21):10584-95. PubMed ID: 25301736
[TBL] [Abstract][Full Text] [Related]
5. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
Luo Y; Liang F; Zhang ZY
Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells.
Thanh HD; Lee S; Nguyen TT; Huu TN; Ahn EJ; Cho SH; Kim MS; Moon KS; Jung C
Sci Rep; 2024 Jun; 14(1):14341. PubMed ID: 38906916
[TBL] [Abstract][Full Text] [Related]
7. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
Kumar B; Koul S; Petersen J; Khandrika L; Hwa JS; Meacham RB; Wilson S; Koul HK
Cancer Res; 2010 Jan; 70(2):832-41. PubMed ID: 20068172
[TBL] [Abstract][Full Text] [Related]
8. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase M2 inhibits the progression of bladder cancer by targeting MAKP pathway.
Zhu Q; Hong B; Zhang L; Wang J
J Cancer Res Ther; 2018 Sep; 14(Supplement):S616-S621. PubMed ID: 30249877
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Jia ZC; Wan YL; Tang JQ; Dai Y; Liu YC; Wang X; Zhu J
Int J Colorectal Dis; 2012 Apr; 27(4):437-45. PubMed ID: 22076613
[TBL] [Abstract][Full Text] [Related]
11. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
Park SY; Kim YH; Kim Y; Lee SJ
Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
[TBL] [Abstract][Full Text] [Related]
12. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.
Dilly AK; Ekambaram P; Guo Y; Cai Y; Tucker SC; Fridman R; Kandouz M; Honn KV
Int J Cancer; 2013 Oct; 133(8):1784-91. PubMed ID: 23526143
[TBL] [Abstract][Full Text] [Related]
13. ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.
Ghosh S; Basu M; Roy SS
J Biol Chem; 2012 Apr; 287(18):15001-15. PubMed ID: 22270366
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
15. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
16. MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
Pei J; Lou Y; Zhong R; Han B
Tumour Biol; 2014 Jul; 35(7):6673-8. PubMed ID: 24705809
[TBL] [Abstract][Full Text] [Related]
17. GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.
Zhang Q; Zhuang J; Deng Y; Zhao X; Tang B; Yao D; Zhao W; Chang C; Lu Q; Chen W; Zhang S; Ji C; Cao L; Guo H
Oncotarget; 2015 Oct; 6(31):32177-92. PubMed ID: 26375441
[TBL] [Abstract][Full Text] [Related]
18. Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer.
Do MH; To PK; Cho YS; Kwon SY; Hwang EC; Choi C; Cho SH; Lee SJ; Hemmi S; Jung C
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201920
[TBL] [Abstract][Full Text] [Related]
19. Anti‑metastatic effects of arctigenin are regulated by MAPK/AP‑1 signaling in 4T‑1 mouse breast cancer cells.
Lee MG; Lee KS; Nam KS
Mol Med Rep; 2020 Mar; 21(3):1374-1382. PubMed ID: 32016480
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis.
Wang XF; Zhou QM; Lu YY; Zhang H; Huang S; Su SB
Expert Opin Ther Targets; 2015 May; 19(5):577-87. PubMed ID: 25828376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
